Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)

BACKGROUND: Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have substantially improved anticoagulation therapy for prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). The available routine care data have demonstrated the safety of different NOACs; howeve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cardiovasc Disord
Asıl Yazarlar: De Caterina, Raffaele, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Weiss, Thomas W., Waltenberger, Johannes, Steffel, Jan, de Groot, Joris R., Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Kerschnitzki, Michael, Reimitz, Paul-Egbert, Kirchhof, Paulus
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625115/
https://ncbi.nlm.nih.gov/pubmed/31299906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-019-1144-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller